Patents Examined by Scarlett Goon
-
Patent number: 9770407Abstract: The present invention is directed to a carbamazepine-cyclodextrin inclusion complex useful for the parenteral administration of carbamazepine. The carbamazepine-cyclodextrin inclusion complex is prepared by the admixture of a modified cyclodextrin and carbamazepine in a physiologically acceptable fluid. Modified cyclodextrins include 2-hydroxypropyl-beta-cyclodextrin and sulfoalkyl cyclodextrins. More particularly, the sulfoalkyl cyclodextrins are those described and disclosed in U.S. Pat. Nos. 5,134,127 and 5,376,645. A physiologically acceptable fluid includes sterile isotonic water, Ringer's lactate, D5W (5% dextrose in water), physiological saline, and similar fluids suitable for parenteral administration.Type: GrantFiled: October 11, 2013Date of Patent: September 26, 2017Assignee: LUNDBECK PHARMACEUTICALS LLCInventors: James Cloyd, Angela Birnbaum, Ilo Leppik, Stephen D. Collins
-
Patent number: 9629797Abstract: The present invention is directed to a carbamazepine-cyclodextrin inclusion complex useful for the parenteral administration of carbamazepine. The carbamazepine-cyclodextrin inclusion complex is prepared by the admixture of a modified cyclodextrin and carbamazepine in a physiologically acceptable fluid. Modified cyclodextrins include 2-hydroxypropyl-beta-cyclodextrin and sulfoalkyl cyclodextrins. More particularly, the sulfoalkyl cyclodextrins are those described and disclosed in U.S. Pat. Nos. 5,134,127 and 5,376,645. A physiologically acceptable fluid includes sterile isotonic water, Ringer's lactate, D5W (5% dextrose in water), physiological saline, and similar fluids suitable for parenteral administration.Type: GrantFiled: July 12, 2012Date of Patent: April 25, 2017Assignee: LUNDBECK PHARMACEUTICALS LLCInventors: James Cloyd, Angela Birnbaum, Ilo Leppik, Stephen D. Collins
-
Patent number: 9593102Abstract: Piperidine compounds and pharmaceutically useful salts thereof, a pharmaceutical composition including an effective amount of the racemic or enantiomerically enriched piperidine compounds to treat gastrointestinal diseases, and a method of treating gastrointestinal diseases in a mammal are provided.Type: GrantFiled: January 17, 2014Date of Patent: March 14, 2017Assignee: SK BIOPHARMACEUTICALS CO., LTD.Inventors: Coo-Min Chung, Hyung-Jin Jun, Jin-Sung Kim, Hui-Ho Kim, Hye-Kyung Min, Yong-Gil Kim, Jong-Gil Choi, Hongwook Kim
-
Patent number: 9539215Abstract: A method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery. Controlled delivery of an anti-inflammatory, chemopreventive drug is achieved by an enzyme-triggered drug release mechanism via degradation of encapsulated hydrogels. The hydro- and organo-gelators are synthesized in high yields from renewable resources by using a regioselective enzyme catalysis and a known chemopreventive and anti-inflammatory drug, curcumin, is encapsulated in the gel matrix and released by enzyme triggered delivery. The release of the drug occurs at the physiological temperature and control of the drug release rate is achieved by manipulating the enzyme concentration and temperature. The by-products formed after the gel degradation clearly demonstrated the site specificity of degradation of the gelator by enzyme catalysis.Type: GrantFiled: January 26, 2015Date of Patent: January 10, 2017Assignee: RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORKInventors: George John, Praveen Vemula
-
Patent number: 9539272Abstract: This invention provides methods for treating a subject afflicted with cancer, comprising concurrently administering (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide. This invention also provides methods for inducing the death of a transformed cell such as a cancer cell, comprising concurrently contacting the cell with (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide.Type: GrantFiled: July 2, 2010Date of Patent: January 10, 2017Assignee: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCHInventors: Paul A. Marks, Weisheng Xu, Mandana Namdar
-
Patent number: 9522129Abstract: Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.Type: GrantFiled: February 8, 2013Date of Patent: December 20, 2016Assignee: Velicept Therapeutics, Inc.Inventors: Stephen Caltabiano, Eliot Ohlstein, Stewart McCallum
-
Patent number: 9518077Abstract: The present disclosure provides methods for producing chitosan derivatives and the derivatives formed by these methods. The processes of the present disclosure utilize electrochemical methods to functionalize and/or modify amine and/or hydroxyl groups present on chitosan, to form new derivatives. In embodiments, a chloro-chitosan derivative may be prepared. The altered cationic affinity of these derivatives make them excellent candidates for biomedical applications, including pharmaceuticals, as well as food applications.Type: GrantFiled: February 1, 2013Date of Patent: December 13, 2016Assignee: The Research Foundation for the State University of New YorkInventors: Gary P. Halada, Prashant Kumar Jha
-
Patent number: 9504747Abstract: This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, L and X are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.Type: GrantFiled: March 7, 2014Date of Patent: November 29, 2016Assignee: Novartis AGInventors: Jeremy Lee Baryza, Rohan Eric John Beckwith, Keith Bowman, Crystal Byers, Tanzina Fazal, Gabriel Grant Gamber, Cameron Chuck-munn Lee, Ritesh Bhanudasji Tichkule, Chandra Vargeese, Shuangxi Wang, Laura Ellen West, Thomas Zabawa, Junping Zhao
-
Patent number: 9492550Abstract: The presently disclosed and claimed inventive concept(s) relates to a polymer for enhancing drug performance and improving processability. Specifically, the polymer comprises hydroxypropyl methyl cellulose acetate succinate (HPMC-AS). On the HPMC-AS, the percentage of total succinoyl degree of substitution is less than 12% at C6-OH position and greater than 53% at C3-OH, and the percentage of total acetyl degree of substitution is greater than 32% at C6-OH position.Type: GrantFiled: February 21, 2014Date of Patent: November 15, 2016Assignee: Hercules LLCInventors: Todd A. Brugel, Tuyen T. Nguyen, Sangrama Sahoo, Divya Tewari, Yuda Zong
-
Patent number: 9464166Abstract: In a process for producing 3,4? and/or 4,4? dimethyl-substituted biphenyl compounds, a feed comprising toluene is contacted with hydrogen in the presence of a hydroalkylation catalyst under conditions effective to produce a hydroalkylation reaction product comprising (methylcyclohexyl)toluenes. At least part of the hydroalkylation reaction product is dehydrogenated in the presence of a dehydrogenation catalyst under conditions effective to produce a dehydrogenation reaction product comprising a mixture of dimethyl-substituted biphenyl isomers. The dehydrogenation reaction product is then separated into at least a first stream containing at least 50% of 3,4? and 4,4? dimethylbiphenyl isomers by weight of the first stream and at least one second stream comprising one or more 2,x? (where x? is 2?, 3?, or 4?) and 3,3? dimethylbiphenyl isomers.Type: GrantFiled: September 8, 2014Date of Patent: October 11, 2016Assignee: ExxonMobil Chemical Patents Inc.Inventors: Jihad M. Dakka, Lorenzo C. DeCaul, Keith H. Kuechler, Neeraj Sangar, Michael Salciccioli, Alan A. Galuska, Gary D. Mohr
-
Patent number: 9464022Abstract: A method of transforming biomass into lactic acid using modified beta zeolites is disclosed. The one-step preparation process of preparing catalyst in the invention is mild, economical and convenient. The biomass used as precursor is economic and easy to get. Meanwhile, the reaction process doesn't need to be protected by noble gases with high pressure. The catalyst can be reused and the yield of lactic acid is high.Type: GrantFiled: October 30, 2015Date of Patent: October 11, 2016Assignee: TONGJI UNIVERSITYInventors: Yalei Zhang, Zheng Shen, Wenjie Dong, Xuefei Zhou
-
Patent number: 9453040Abstract: A glycodendrimer comprising: a) a non-toxic dendrimer polypropyletherimine core supporting on average in the range of 9 to 64 terminal carboxylic acid groups, and b) conjugated to said core in the range of 2 to 8 amino sugars or a sulphate amino sugar selected from the group consisting of glucosamine, N-acetyl glucosamine, mannosamine, N-acetylmannosamine, galactosamine, a sulphate of any one of the same and a combination thereof, wherein each sugar is linked directly through a zero length amide bond with a residue of a terminal carboxylic acid group. The invention also extends to defined populations comprising said glycodendrimer molecules, pharmaceutical compositions comprising said molecules or populations, process for preparing the molecules and formulations, and therapeutic uses of the molecules, populations and compositions.Type: GrantFiled: August 22, 2011Date of Patent: September 27, 2016Assignee: IMPERIAL INNOVATIONS LIMITEDInventors: Sunil Shaunak, Ian Alfred Teo
-
Patent number: 9439915Abstract: Described herein are compositions useful in anticancer treatment. The compositions are composed of (a) an O2-aryl substituted diazeniumdiolate and (b) an amphiphile, wherein the amount of amphiphile is sufficient to produce a liposome or micelle. The compositions described herein provide numerous advantages such as increased solubility and stability of the O2-aryl substituted diazeniumdiolate in vivo. The compositions also do not induce hypotension. Methods for using the compositions in anticancer treatment are also described herein.Type: GrantFiled: April 13, 2015Date of Patent: September 13, 2016Assignee: University of Utah Research FoundationInventors: Paul J. Shami, Ken M. Kosack
-
Patent number: 9399655Abstract: A catalytic glycosylation method comprising: installing thioether to an anomeric carbon of a carbohydrate; and catalytically activating the thioether with a non-oxophilic Lewis acid. The thioether may comprise an anomerically stable thioether leaving group. The catalytic glycosylation method may further comprise: utilizing an acid-sensitive ester protecting group as permanent protecting group or using a reactivity-based one-pot glycosylation that employs a single-component catalyst to accelerate an oligosaccharide assembly process. A protecting group to mask hydroxyl functionalities in the production of oligosaccharides, natural products or any molecule having a hydroxyl group comprising an acid-labile ester protecting group.Type: GrantFiled: June 6, 2013Date of Patent: July 26, 2016Assignee: University of Pittsburgh—Of The Commonwealth System of Higher EducationInventor: Xinyu Liu
-
Patent number: 9394219Abstract: Method for producing synthesis gas for methanol production The present invention relates to a method for producing synthesis gas from a hydrocarbon containing feed, which synthesis gas is particularly suitable for subsequent use in methanol production. In this method, a hydrocarbon containing feed, particularly natural gas (100), is subjected to catalytic partial oxidation (CPO) (2), followed by the water gas shift (WGS) (4) reaction of a part of the reformed feed. At least part of the shifted feed is then subjected to hydrogen purification, preferably by pressure swing adsorption (PSA) (5) to obtain pure hydrogen (108), which hydrogen is subsequently combined with the remaining parts of the feeds to yield synthesis gas particularly suitable for methanol synthesis. The recombined stream preferably has an R ratio, being the molar ratio (H2?CO2)/(CO+CO2), in the range 1.9-2.2 and preferably about 2.Type: GrantFiled: October 25, 2012Date of Patent: July 19, 2016Assignee: STAMICARBON B.V.Inventors: Gaetano Iaquaniello, Barbara Cucchiella, Elena Antonetti
-
Patent number: 9388109Abstract: With respect to reduced coenzyme Q10, there has been no report about the presence of crystal polymorphism, and it has been considered that a conventionally obtained crystal form is only one form. The present invention relates to a reduced coenzyme Q10 crystal having an endothermic peak indicating melting at 54±2° C. during temperature rise at a rate of 5° C./min by differential scanning calorimetry (DSC), and/or to a reduced coenzyme Q10 crystal showing characteristic peaks at diffraction angles (2?±0.2°) of 11.5°, 18.2°, 19.3°, 22.3°, 23.0° and 33.3° by powder X-ray (Cu—K?) diffraction. The crystal form is a novel reduced coenzyme Q10 crystal which has a higher melting point and a lower solubility in a solvent, and is more excellent in stability than the conventionally known reduced coenzyme Q10 crystal.Type: GrantFiled: June 21, 2012Date of Patent: July 12, 2016Assignee: KANEKA CORPORATIONInventors: Hideo Kawachi, Shiro Kitamura, Yasuyoshi Ueda
-
Patent number: 9382177Abstract: A process is disclosed for producing ethanol, comprising contacting hydrogen and a feed stream comprising acetic acid in a reactor in the presence of a catalyst comprising a binder and a mixed oxide comprising a promoter metal and tin, and preferably also comprising cobalt. The promoter metal is selected from the group consisting of rhenium, ruthenium, rhodium, palladium, osmium, iridium, platinum, and combinations thereof. The feed stream may comprises pure acetic acid or may comprise a mixture of 50 to 95 wt. % acetic acid and 5 to 50 wt. % ethyl acetate.Type: GrantFiled: April 28, 2014Date of Patent: July 5, 2016Assignee: CELANESE INTERNATIONAL CORPORATIONInventors: Zhenhua Zhou, Victor J. Johnston, Heiko Weiner
-
Patent number: 9376647Abstract: The present invention relates to novel non-aqueous gels of natural oils and their derivatives and provides a novel process for the gelation of natural oils and their derivatives that does not require the addition of gellants or the irreversible heat bodying of the oil. The gels and method of the present invention are applicable to a wide range of natural oils, and the method is easily tailored to provide thermoreversible gels of any desired viscosity. The natural oil based gels of the present invention and the method of their preparation have many advantages over the prior art. The natural oil based gels provided have exemplary properties and find use in a variety of applications.Type: GrantFiled: February 25, 2013Date of Patent: June 28, 2016Assignee: Ethox Chemicals, LLCInventor: James T. Tanner
-
Patent number: 9371316Abstract: The present application provides novel pyridine compounds and pharmaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. These compounds are useful in inhibiting CYP17 activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with CYP17 activity. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer, such as prostate cancer.Type: GrantFiled: August 18, 2014Date of Patent: June 21, 2016Assignee: Asana Biosciences, LLCInventors: Roger Astbury Smith, Nicholas James Laping, Aranapakam M. Venkatesan, Raghava Reddy Kethiri, Chandregowda Venkateshappa, Bheemashankar Kulkarni, Purushottam Dewang, Rajendra Kristam, Rajesh Devraj
-
Patent number: 9371398Abstract: Provided is a method for efficiently preparing alkali cellulose having a uniform alkali distribution. More specifically, provided are a methods for preparing alkali cellulose comprising a contact filtration step of bringing a pulp into contact with an alkali metal hydroxide solution on a moving filtration plane for vacuum filtration to collect a contact product remaining on the filtration plane, and a draining step of draining the contact product; and a method of preparing cellulose ether by using the alkali cellulose. Also provided is an apparatus for preparing alkali cellulose comprising a continuous horizontal vacuum filter type contactor.Type: GrantFiled: February 16, 2012Date of Patent: June 21, 2016Assignee: Shin-Etsu Chemical Co., Ltd.Inventor: Mitsuo Narita